{"id":4624,"date":"2026-03-24T21:57:29","date_gmt":"2026-03-24T21:57:29","guid":{"rendered":"https:\/\/cehre.net\/?p=4624"},"modified":"2026-03-24T21:57:29","modified_gmt":"2026-03-24T21:57:29","slug":"doctors-reveal-the-one-blod-type-which-has-the-lowest-risk-of-cancer","status":"publish","type":"post","link":"https:\/\/cehre.net\/?p=4624","title":{"rendered":"Doctors reveal the one blod type which has the lowest risk of cancer"},"content":{"rendered":"\n<p>While most people only consider their blood type during a routine physical or a Red Cross donation drive, a growing body of clinical research suggests that these cellular markers may provide a critical window into an individual\u2019s long-term health trajectory\u2014specifically regarding their susceptibility to oncological diseases.<\/p>\n\n\n\n<p>According to a series of longitudinal studies, including a landmark 2015 report, individuals with&nbsp;<strong>Type O blood<\/strong>&nbsp;may possess a unique biological advantage. The data suggests that those within the Type O group have a significantly reduced risk of developing several high-profile malignancies, most notably stomach, pancreatic, and colorectal cancers.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">The Type O Advantage<\/h3>\n\n\n\n<p>In contrast to the \u201cO\u201d group, individuals with&nbsp;<strong>Type A, B, or AB<\/strong>&nbsp;blood types were found to carry a heightened risk profile. Clinical observations have been particularly pointed regarding stomach and pancreatic cancers, where non-O types show a statistically relevant increase in vulnerability.<\/p>\n\n\n\n<p>Beyond oncology, the benefits of Type O appear to extend into cardiovascular health. Researchers have linked the type to a lower overall risk of heart disease. This \u201ccardio-protective\u201d quality is believed to stem from Type O blood naturally possessing fewer clotting factors, which may reduce the likelihood of arterial blockages and related complications.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Understanding the Mechanics<\/h3>\n\n\n\n<p>Despite these findings, the medical community is quick to provide a necessary reality check: while blood type may influence the&nbsp;<em>risk<\/em>&nbsp;of contracting the disease, it does not appear to have any measurable impact on&nbsp;<strong>cancer mortality rates<\/strong>. Once a diagnosis is made, the blood type itself ceases to be a primary factor in the patient\u2019s ultimate prognosis.<\/p>\n\n\n\n<p>Furthermore, the majority of the population remains \u201cblood type illiterate,\u201d with most individuals only discovering their specific classification\u2014<strong>A, B, AB, or O (positive or negative)<\/strong>\u2014during an emergency or medical procedure. These classifications are determined by the presence or absence of specific antigens and the Rh protein on the surface of red blood cells.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">A Piece of a Larger Puzzle<\/h3>\n\n\n\n<p>While the data regarding Type O is compelling, oncology experts stress that blood type is far from a definitive \u201cshield.\u201d<\/p>\n\n\n\n<p>\u201cKnowing your blood type is an excellent tool for personal health literacy,\u201d says one lead researcher. \u201cHowever, it is just one variable in an incredibly complex equation. Genetics, lifestyle choices, environmental exposure, and regular screenings remain the primary pillars of cancer prevention and early detection.\u201d<\/p>\n\n\n\n<p>As the field of personalized medicine continues to evolve, these findings offer a new layer of data for clinicians looking to identify high-risk patients before symptoms ever appear.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>While most people only consider their blood type during a routine physical or a Red Cross donation drive, a growing body of clinical research suggests that these cellular markers may provide a critical window into an individual\u2019s long-term health trajectory\u2014specifically regarding their susceptibility to oncological diseases. According to a series of longitudinal studies, including a &hellip;<\/p>\n","protected":false},"author":1,"featured_media":4625,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4624","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/posts\/4624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cehre.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4624"}],"version-history":[{"count":1,"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/posts\/4624\/revisions"}],"predecessor-version":[{"id":4626,"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/posts\/4624\/revisions\/4626"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cehre.net\/index.php?rest_route=\/wp\/v2\/media\/4625"}],"wp:attachment":[{"href":"https:\/\/cehre.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cehre.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cehre.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}